6734.TWO iXensor Co., Ltd.

Healthcare Medical Devices Taiwan OTC Exchange
5.25 TWD
Close of Nov 6, 2026
4.18 18.50
Market cap
TWD 221M
P/E
-
P/B
25.06x
ROE
-203.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6734.TWO undervalued?

Graham number

The Graham number of iXensor Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

iXensor Co., Ltd. fundamental analysis

No fundamental analysis for iXensor Co., Ltd. yet.

iXensor Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About iXensor Co., Ltd.

iXensor Co., Ltd. engages in the research, development, and manufacture of medical devices. It offers PixoTest Vision Analysis System and PixoHealth Vision application for chronic disease monitoring, as well as Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management. The company was founded in 2012 and is based in Taipei, Taiwan.

Full company profile